HIPAA vs DPDP: one product, two postures.
Shared primitives for regulated AI — access control, logs, minimization — and the jurisdiction-specific deltas US and Indian buyers actually diligence.
·10 min read
TL;DR
Do not clone a HIPAA checklist onto an India launch or a DPDP notice onto a US clinical product. Build a shared spine — minimization, access control, auditability, vendor control — then layer HIPAA BA/safeguard sequencing for US healthcare and DPDP notice/purpose/consent for Indian personal data.
What should a dual-market AI product share between HIPAA and DPDP?
Data-flow diagrams, least-privilege access, encryption in transit and at rest, audit logs for sensitive actions and inference, retention rules, vendor inventories, and incident response. Those primitives help both postures. Jurisdiction theater without the spine helps neither.
Brandlabs starts every regulated engagement with the spine:
- What data enters the model path?
- Who can trigger inference?
- What is logged, redacted, retained?
- Which vendors touch prompts or embeddings?
- How do we revoke access and stop processing?
Only then do we specialize language and contracts for the buyer’s market.
Where do HIPAA and DPDP diligence diverge for AI startups?
US healthcare diligence leans BAAs, PHI boundaries, workforce training, and technical safeguards around ePHI. Indian diligence leans fiduciary/processor roles, notice quality, purpose limitation, consent and withdrawal, and cross-border transfer posture. Same model API; different questions in the security questionnaire.
HIPAA-shaped questions we hear:
- Will you sign a BAA?
- How is PHI kept out of training sets?
- Can you produce an audit trail for access and disclosures?
DPDP-shaped questions we hear:
- What is the purpose of each AI feature?
- How is consent captured and withdrawn?
- Which overseas processors see personal data?
If your one-pager answers only one column, you will stall sales in the other market.
How do you sequence a product that must sell in both markets?
Ship the shared spine first, then enable market packs: US pack (BAA-ready vendors, PHI gates, HIPAA-oriented audit events) and India pack (notice/consent UX, purpose flags, transfer documentation). Feature flags beat forked codebases. Never let a US demo path silently process Indian personal data under the wrong notice.
Practical rules:
- Tenant or deployment “market posture” config
- Separate eval fixtures for PHI-like vs personal-data consent cases
- Vendor matrix with columns for BAA and DPDP processor terms
- Sales engineers trained not to overclaim “HIPAA compliant” or “DPDP compliant” as a sticker
Compliance is architecture plus contracts plus honesty. Stickers are marketing debt.
Frequently asked questions
Can one SOC 2 report replace both?
SOC 2 helps credibility but does not replace BAAs, PHI handling design, or DPDP notice/consent work. Treat it as evidence, not a passport.
Should we pick one market first?
Often yes for focus — but still build the shared spine so the second market is a pack, not a rewrite.
Is this legal advice?
No. Counsel in each jurisdiction owns legal determinations. We implement the product posture those determinations require.